IP Library Granted Patent US 8,758,427
Granted Patent B2
US 8,758,427 · App. 13/310,503 · Granted Jun 24, 2014

Elongated expandable member for occluding varicose veins

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,758,427
App. No.
13/310,503
Granted
Jun 24, 2014
Kind
B2
Abstract

Assemblies, kits, and methods for occluding a vascular vessel, such as a varicose vein, are disclosed. An assembly can include a removable inner member, a removable outer member, and an elongated expandable member positioned in a compressed form between portions of the inner and outer members. To facilitate their removal, one or both of the inner and outer members can include a handle coupled to a proximal end. The elongated expandable member can include a gelatin material or a collagen material that is configured, when wetted, to expand from a compressed first diametrical size to a second larger diametrical size within a time period of 5 minutes or less. At the second larger diametrical size, the gelatin or collagen material can occlude a vascular vessel for a period of at least 20 days without degrading.

Claims (15)

1. An assembly, comprising:

a removable inner member, the inner member including a handle coupled to a proximal end portion;

a removable outer member, the outer member including an impermeable material; and

an elongated expandable member, including a gelatin material or a collagen material having a degree of vapor cross-linking characterized by Lysine residuals of 1.5% or less, positioned in a compressed form between a longitudinal inner surface of the outer member and a longitudinal outer surface of the inner member,

the elongated expandable member longitudinally positionable in alignment within a portion of the natural flow duct of a vascular vessel and configured to expand and occlude the duct of the vascular vessel following in situ separation and removal of the outer member.

2. The assembly of claim 1 , wherein the degree of cross-linking is configured to prevent the gelatin or collagen material from degrading for a period of at least 20 days.

3. The assembly of claim 1 , wherein the elongated expandable member includes a density between 0.005 g/cm 3 and 0.010 g/cm 3 .

4. The assembly of claim 1 , wherein the elongated expandable member includes a wicking agent selected from a salt or a sugar.

5. The assembly of claim 1 , wherein the elongated expandable member is configured to expand, when wetted, from a compressed first diametrical size to a second larger diametrical size, the second larger diametrical size at least 5 times the first diametrical size.

6. The assembly of claim 5 , wherein the elongated expandable member includes a length of at least 10 centimeters, and wherein the elongated expandable member completely expands in situ from the first diametrical size to the second larger diametrical size within a time period of 5 minutes or less.

7. The assembly of any one of claim 5 or 6 , wherein the second larger diametrical size of the elongated expandable member is substantially equal to a pre-wetted size of the member before being compressed and positioned between the longitudinal inner surface of the outer member and the longitudinal outer surface of the inner member.

8. The assembly of claim 1 , wherein the elongated expandable member includes an antimicrobial agent selected from a silver compound, chlorhexidine, an antibiotic, or an iodine-containing agent.

9. The assembly of claim 1 , wherein the elongated expandable member includes a pH adjuster in a concentration that results in the member having a pH greater than 5.7, the pH adjuster selected from hydrochloric acid, sodium hydroxide, or a buffer.

10. The assembly of claim 1 , wherein the outer member includes a handle, configured to detachably couple to the handle of the inner member, at a proximal end portion.

11. The assembly of claim 1 , wherein the elongated expandable member includes a drug having a property of promoting tissue in-growth to accelerate vascular vessel closure.

Assignments (7)
MERGER Recorded Jan 15, 2024
From: TELEFLEX LIFE SCIENCES III LLC
To: TELEFLEX LIFE SCIENCES LLC
Reel/Frame 066305/0817 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2024
From: TELEFLEX LIFE SCIENCES LIMITED
To: TELEFLEX LIFE SCIENCES III LLC
Reel/Frame 066305/0565 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2020
From: TELEFLEX MEDICAL DEVICES S.À.R.L.
To: TELEFLEX LIFE SCIENCES LIMITED
Reel/Frame 051519/0873 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2020
From: TELEFLEX INNOVATIONS S.À.R.L.
To: TELEFLEX MEDICAL DEVICES S.À.R.L.
Reel/Frame 051519/0816 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2017
From: VASCULAR SOLUTIONS LLC
To: TELEFLEX INNOVATIONS S.À.R.L.
Reel/Frame 044822/0837 →
CHANGE OF NAME Recorded Dec 8, 2017
From: VASCULAR SOLUTIONS, INC.
To: VASCULAR SOLUTIONS LLC
Reel/Frame 044767/0246 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2011
From: ROOT, HOWARD; MURTO, JAMES; PENEGOR, STEPHEN; SUTTON, GREGG
To: VASCULAR SOLUTIONS, INC.
Reel/Frame 027318/0745 →